These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 9235976)

  • 1. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
    Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
    Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
    Tautz N; Kaiser A; Thiel HJ
    Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An uniquely purified HCV NS3 protease and NS4A(21-34) peptide form a highly active serine protease complex in peptide hydrolysis.
    Sardana VV; Blue JT; Zugay-Murphy J; Sardana MK; Kuo LC
    Protein Expr Purif; 1999 Aug; 16(3):440-7. PubMed ID: 10425166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
    Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z
    Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
    J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
    Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
    Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.
    Ingallinella P; Altamura S; Bianchi E; Taliani M; Ingenito R; Cortese R; De Francesco R; Steinkühler C; Pessi A
    Biochemistry; 1998 Jun; 37(25):8906-14. PubMed ID: 9636032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction.
    Leinbach SS; Bhat RA; Xia SM; Hum WT; Stauffer B; Davis AR; Hung PP; Mizutani S
    Virology; 1994 Oct; 204(1):163-9. PubMed ID: 8091650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
    Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
    Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
    Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
    Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
    Failla CM; Pizzi E; De Francesco R; Tramontano A
    Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide.
    Bianchi E; Urbani A; Biasiol G; Brunetti M; Pessi A; De Francesco R; Steinkühler C
    Biochemistry; 1997 Jun; 36(25):7890-7. PubMed ID: 9201934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
    Niyomrattanakit P; Yahorava S; Mutule I; Mutulis F; Petrovska R; Prusis P; Katzenmeier G; Wikberg JE
    Biochem J; 2006 Jul; 397(1):203-11. PubMed ID: 16489931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.